1. 119 UPDATE ON THE MULTICENTER MDS BIOREGISTRY PROJECT OF THE "KREBSHILFE-VERBUNDFORSCHUNGSPROJEKT MDS" OF THE GERMAN MDS STUDY GROUP. Issue 1 (April 2015) Authors: Schemenau, I.; Strupp, C.; Wulfert, M.; Schroeder, T.; Xicoy, B.; Nusch, A.; Langer, W.; Kalhori, N.; Haase, D.; Brümmendorf, T.; Schütte, J.; Ganser, A.; Parmentier, S.; Schulte, K.; Plewe, D.; Losem, C.; Biekmann, E.; Hoffmann, W.; Hahn, L.; Neise, M. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 156 A NOVEL PCR-BASED ASSAY FOR TARGETED QUANTIFICATION OF DEL(5Q) IN MYELODYSPLASTIC SYNDROMES. Issue 1 (April 2015) Authors: Jann, J.C.; Nowak, D.; Nolte, F.; Fey, S.; Nowak, V.; Obländer, J.; Pressler, J.; Fabarius, A.; Haferlach, C.; Medyouf, H.; Hofmann, W.K.; Mossner, M. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 227 CD71+ ERYTHROPROGENITOR CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES DISPLAY DISTURBED REGULATION OF ERYTHROPOIESIS STIMULATING ERYTHROFERRONE (ERFE) IN ASSOCIATION WITH DIFFERENTIAL PROGNOSTIC SIGNIFICANCE. Issue 1 (April 2015) Authors: Mossner, M.; Stöhr, A.; Nolte, F.; Jann, J.C.; Fey, S.; Nowak, V.; Obländer, J.; Pressler, J.; Baldus, C.D.; Schulze, T.J.; Neumann, M.; Nowak, D.; Hofmann, W.K. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 65 MYELODYSPLASTIC SYNDROMES ARE CHARACTERIZED BY RECURRENT PATTERNS IN PATIENT-INDIVIDUAL MUTATIONAL HIERARCHIES THAT ARE SUBJECT TO HIGHLY DYNAMIC SUBCLONAL EVOLUTION DURING THERAPY AND DISEASE PROGRESSION. (April 2015) Authors: Mossner, M.; Jann, J.C.; Wittig, J.; Nolte, F.; Fey, S.; Nowak, V.; Obländer, J.; Pressler, J.; Müdder, K.; Klein, C.; Zens, B.; Platzbecker, U.; Schönefeldt, C.; Fabarius, A.; Blum, H.; Schulze, T.J.; Haferlach, C.; Trumpp, A.; Hofmann, W.K.; Medyouf, H. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Erythroferrone (ERFE) and Growth Differentiation Factor 15 (GDF15) Are Overexpressed in Erythroprogenitor Cells of MDS Patients and Associated with Survival. (April 2017) Authors: Mossner, M.; Stöhr, A.; Jann, J.C.; Nolte, F.; Nowak, V.; Oblaender, J.; Pressler, J.; Xanthopoulos, C.; Palme, I.; Baldus, C.; Schulze, T.; Boch, T.; Metzgeroth, G.; Neumann, M.; Hofmann, W.K.; Nowak, D. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Integrated Analysis of Epigenetic and Genetic Changes During MDS Progression Reveals the Tight Association of Epigenetic Changes with Genetic Selection. (April 2017) Authors: Pohl, S.; Heudobler, D.; Loyola, V. Bengt Pastor; Gebhard, C.; Mossner, M.; Jann, J.C.; Hirabayashi, S.; Nowak, D.; Wlodarski, M.; Hofmann, W.K.; Niemeyer, C.; Rehli, M. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Labile Plasma Iron Predicts for Survival in Patients Undergoing Allogeneic Stemcell-Transplantation – Results from the Prospective Multicenter German-Austrian Allive Trial. (April 2017) Authors: Wermke, M.; Eckoldt, J.; Götze, K.S.; Klein, S.A.; de Wreede, L.C.; Bug, G.; Stölzel, F.; von Bonin, M.; Schetelig, J.; Laniado, M.; Plodeck, V.; Hofmann, W.K.; Ehninger, G.; Bornhäuser, M.; Dominik, W.; Theurl, I.; Platzbecker, U. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Response Signature to the CD95-Ligand Inhibitor Asunercept Involve Low Serum P53 and Rankl. (April 2017) Authors: Luft, T.; Radujkovic, A.; Nowak, D.; Fricke, H.; Kunz, C.; Hofmann, W.K.; Nolte, F.; Dreger, P.; Boch, T. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and Efficacy of the Cd95-Ligand Inhibitor Asunercept in Transfusion-Dependent Patients with Low and Intermediate Risk MDS. (April 2017) Authors: Boch, T.; Luft, T.; Mossner, M.; Jann, J.C.; Nowak, D.; Schumann, C.; Klemmer, J.; Brendel, S.; Fricke, H.; Kunz, C.; Hofmann, W.K.; Nolte, F. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Transcriptomic Changes upon Ageing of Bone Marrow Derived Mesenchymal Stromal Cells and Onset of MDS. (April 2017) Authors: Jann, J.C.; Mossner, M.; Nolte, F.; Boch, T.; Nowak, V.; Palme, I.; Obländer, J.; Pressler, J.; Xanthopoulos, C.; Röhl, H.; Hofmann, W.K.; Nowak, D. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗